IDO1 and melanoma: We demonstrated that the B16 melanoma expressing a loss-of-function mutant of IDO1 catalytic activity proliferated faster than the wild-type tumor and expressed a constitutive hyperactivated Ras–ERK signaling pathway (19), demonstrating that the non-enzymatic function of IDO1 was also relevant for tumor proliferation.